| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.051 | 0.8 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |